Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Commissioner hunt

This article was originally published in The Gray Sheet

Executive Summary

Lester Crawford, DVM/PhD, director of Georgetown University's Center for Food & Nutrition, is being considered as a candidate to assume FDA's top spot. His selection would suggest an emphasis on FDA's food safety programs; other potential nominees such as Stanford University cardiologist Paul Yock, MD, have backgrounds more relevant to the medical product review functions of the agency. In addition to food and veterinary medicine expertise, Crawford brings an understanding of biomedical research advocacy. In 1997, he testified before Congress on behalf of the National Association for Biomedical Research to defend cloning research in animals. Crawford has also served as a voting consultant on FDA's Transmissible Spongiform Encephalopathies Advisory Committee

You may also be interested in...



HHS Secretary Thompson Secures FDA Spot For Candidate Crawford

The appointment of former Virginia Tech Center for Food & Nutrition Policy chief Lester Crawford, PhD/DVM, as acting FDA commissioner puts FDA in the hands of HHS Secretary Thompson's preferred choice to head the agency

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015323

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel